↓ Skip to main content

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Overview of attention for article published in Journal of Translational Medicine, July 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

twitter
1 tweeter
patent
8 patents
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
188 Dimensions

Readers on

mendeley
152 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
Published in
Journal of Translational Medicine, July 2010
DOI 10.1186/1479-5876-8-71
Pubmed ID
Authors

Chrystelle Brignone, Maya Gutierrez, Fawzia Mefti, Etienne Brain, Rosana Jarcau, Frédérique Cvitkovic, Nabil Bousetta, Jacques Medioni, Joseph Gligorov, Caroline Grygar, Manon Marcu, Frédéric Triebel

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
Canada 1 <1%
Australia 1 <1%
Unknown 148 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 34 22%
Student > Ph. D. Student 25 16%
Student > Bachelor 16 11%
Student > Master 13 9%
Student > Doctoral Student 11 7%
Other 21 14%
Unknown 32 21%
Readers by discipline Count As %
Medicine and Dentistry 33 22%
Agricultural and Biological Sciences 26 17%
Biochemistry, Genetics and Molecular Biology 23 15%
Immunology and Microbiology 15 10%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Other 12 8%
Unknown 35 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2021.
All research outputs
#2,255,289
of 22,601,066 outputs
Outputs from Journal of Translational Medicine
#358
of 3,933 outputs
Outputs of similar age
#7,374
of 79,856 outputs
Outputs of similar age from Journal of Translational Medicine
#1
of 1 outputs
Altmetric has tracked 22,601,066 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,933 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 79,856 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them